METiS Therapeutics

company

About

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$86M
Industries
Biopharma,Biotechnology,Genetics,Health Care,Machine Learning
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$86M
METiS Therapeutics has raised a total of $86M in funding over 2 rounds. Their latest funding was raised on Dec 7, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 7, 2021 Series A $86M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
METiS Therapeutics is funded by 1 investors. CMBI Zhaoxin Wuji Fund are the most recent investors.
Investor Name Lead Investor Funding Round
CMBI Zhaoxin Wuji Fund Series A